Diabetic Retinopathy: An Era of Change
COPE #85747-TD
Event #126522
COURSE DESCRIPTION:
This course will update you on the current concepts and the era of change regarding the management of diabetic retinopathy. You will fully understand the standard classification of non-proliferative and proliferative diabetic retinopathy. You will be updated on the current treatment for diabetic macular edema and proliferative retinopathy based on current trends guided by numerous clinical trials.
LEARNING OBJECTIVES:
• The attendees will have a template for the accepted classification of retinopathy derived by the ETDRS.
• The attendees will understand the classification of Non Proliferative Diabetic Retinopathy and follow up intervals recommended.
• The attendees will understand the classification of Proliferative Diabetic Retinopathy and current treatment options available based on results of clinical trials
• The attendees will know how clinical trials have molded the management of macular edema and proliferative retinopathy. In addition, earlier intervention with NPDR and the ability to reverse the severity of diabetic retinopathy.
• The attendees will know the definition of clinically significant diabetic macular edema (CSME) and current treatment options. You will know how to differentiate “center” and “non center involved macular edema” as seen with SDOCT imaging.
• The attendees will have a better understanding of how to become more proactive than reactive in the management and referral of patients with Diabetic Retinopathy
Video
Text material
Exam
Certificate
Dr. Jay Haynie
Jay M. Haynie, OD, FAAO
Dr. Jay M. Haynie is a graduate of Pacific University College of Optometry and completed a residency at American Lake Veterans Hospital in 1993 where the focus was on the diagnosis and management of ocular disease. He served as the Executive Clinical Director of Retina and Macula Specialists until 2018 after which time he joined Sound Retina in Tacoma Washington. He is an adjunct clinical professor at Pacific University College of Optometry, a Fellow of the American Academy of Optometry and a fellow of the Optometric Retina Society. He is a clinical investigator and continues to be involved in clinical studies regarding retinal disease management, both as a principle and sub-investigator. He is a published author and has become a nationally recognized speaker on advances in technology and the management of retinal disease.